SLS logo

SLS P/OCF Ratio

Current (TTM)-80.80×
SLS Quarterly P/OCF Ratio (-4167.25× → -368.00×)
High-resolution chart · PNG

SLS p/ocf ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Sellas Life Sciences Group Inc P/OCF Ratio — Quarterly
Period endingP/OCF Ratio
-367.9955×
-82.4776×
-117.2932×
-24.6912×
-28.1739×
-10.4499×
-10.7573×
-10.9297×
-7.0031×
-4.4559×
-6.7673×
-6.7473×
-5.8822×
-2.7766×
-9.5211×
-7.2285×
-7.8524×
-14.852×
-17.6602×
-24.7373×
-34.6053×
-12.3721×
17.6183×
-6.1471×
-5.821×
-1.5846×
-4.96×
-2.4628×
-0.6379×
-4.2404×
-5.8867×
-0.0417×
-2.6061×
-3.033×
2.7366×
-3.2635×
-2.3661×
-2.1987×
-9.0938×
-21.5023×
0×
0×
-140.1251×
-243.2626×
-208.193×
-147.2815×
-155.4824×
-198.6715×
-250.6879×
-324.9192×
-612.4496×
-224.4014×
-233.5532×
-289.9864×
-221.098×
-258.7047×
-147.8835×
-196.078×
-48.6414×
-111.7806×
-83.7672×
-101.6741×
-307.8607×
-210.5203×
-115.8953×
-307.8×
-229.794×
-117.3489×
-203.9306×
-236.5936×
-259.9799×
-427.7514×
-41.2148×
-648.9388×
-543.7199×
-556.4118×
-1,836.416×
-1,120.1447×
-4,167.2517×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.